Presentation Fellows 2012 Everolimus-Eluting Stents: Preclinical Foundation and Clinical Results Presenter: Gregg Stone April 21, 2012
Presentation Long-term (more than 10 years) Clinical Outcomes of First-in-Man Biodegradable PLLA Coronary Stents Presenter: S. Nishio April 16, 2012
Presentation ACC 2012 Two-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents in De Novo Coronary Artery Lesions Presenter: Gregg Stone March 28, 2012
Presentation ACC 2012 Biodegradable Polymer Drug-Eluting Stents Versus Durable Polymer Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention Presenter: Robert A. Byrne March 24, 2012
Presentation PCI Outcomes 2012 Controversy 1: Current Drug-Eluting Stents Are Not Only More Effective But Are Safer Than Bare Metal Stents and Should Be Used in more than 90% of (Stented) Patients Presenter: Gregg W. Stone March 23, 2012
Presentation CTO 2012 Use of Taxus Element Stents for the Angioplasty of a Distal Left Main Complex Lesion with Ostial CTO of the LAD Presenter: Philippe Durand February 24, 2012
Presentation CTO 2012 One Stent vs Two Stents: Evidence-Based Medicine and Cath Lab Practicalities Presenter: David Kandzari February 22, 2012
Presentation CTO 2012 Dedicated Left Main Bifurcation Stents 2: Experience with the Tryton Presenter: Yaron Almagor February 22, 2012
Presentation CTO 2012 Dedicated Left Main Bifurcation Stents 1: Rationale, Landscape, and Development Presenter: Martin Leon February 22, 2012
Presentation CTO 2012 Can IVUS Help Determine Whether One vs. Two Stents Are Necessary? Presenter: Akiko Maehara February 22, 2012
Presentation CTO 2012 Can FFR Help Determine Whether One vs. Two Stents Are Necessary? Presenter: Morton Kern February 22, 2012
Presentation Oclusión con Balón Proximal frente al Filtro de Protección Embólica en Pacientes Sometidos a Colocación de Stents en la Carótida (CAS) Presenter: K. Bijuklic January 25, 2012
Presentation Ensayo Aleatorizado Multicentro Comparador de Amfilimus con Stents Liberadores de Paclitaxel en Lesiones Coronarias Nativas De Novo Presenter: Didier Carri? January 24, 2012
Presentation A Multicenter Randomized Trial Comparing Amphilimus- With Paclitaxel-Eluting Stents in De Novo Native Coronary Artery Lesions Presenter: Didier Carrie January 24, 2012
Presentation ISET 2012 Second- and Third-generation DES: Are All Coated Stents Equal? Presenter: Eberhard Grube January 15, 2012
Presentation ISET 2012 Drug-coated Balloons and Stents in the Periphery: Is There a Future? Presenter: Ron Waksman January 15, 2012
Presentation TCT 2012 Use Of Paclitaxel-Eluting Stents Reduces Target Lesion Revascularization for Dialysis Patients. Presenter: Hirotoshi Watanabe, Kyohei Yamaji, Yoshimitsu Soga, Shinichi Shirai, Kenji Ando, Koyu Sakai, Katsuhiro Kondo, Masashi Iwabuchi, Hiroyoshi Yokoi, Hideyuki Nosaka, Masakiyo Nobuyoshi January 03, 2012
Presentation TCT 2012 Two-Year Outcomes of a Propensity-Matched Comparison of the ION and TAXUS Liberté Paclitaxel-Eluting Stents. Presenter: Dean J. Kereiakes, Louis A. Cannon, John A. Ormiston, Hong Wang, Paul L. Underwood, Keith D. Dawkins January 03, 2012
Presentation TCT 2012 Twelve-Month Clinical Efficacy and Safety of Zotarolimus- versus Everolimus-Eluting Stents in a Series of Asian Population Presenter: SunWon Kim, Seung Woon Rha, Byoung Geol Choi, Amro Elnagar, Sung Il Im, Jin Oh Na, Seong Woo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh January 03, 2012